Communiqués ALPA HEAL Nasdaq

Actions

ALPAU

US02073F2039

Temps Différé Nasdaq Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		-2,60 %	-2,60 %

2023	Alpha Healthcare Acquisition Corp. III présente ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023	CI
2023	Alpha Healthcare Acquisition Corp. III présente ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary	20/03	AQ
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field	18/03	AQ
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	26/02	AQ
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors	16/11	AQ
ALPA HEAL : Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - Form 8-K	16/11	PU
Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics	06/09/23	AQ
ALPA HEAL : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	21/07/23	PU
Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	17/07/23	AQ
Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	14/07/23	BU
Alpha Healthcare Acquisition III : Material Agreement - Form 8-K	10/07/23	PU
Carmell Therapeutics Merger With Alpha Healthcare Acquisition Corp III (Nasdaq: ALPA) July 6, 2023 - Form 8-K	06/07/23	PU
Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination	27/06/23	BU
ALPHA HEALTHCARE ACQUISITION CORP III : Other Events (form 8-K)	02/05/23	AQ
ALPHA HEALTHCARE ACQUISITION CORP III : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	31/03/23	AQ
ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	17/03/23	AQ
Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications	05/01/23	BU
ALPHA HEALTHCARE ACQUISITION CORP III : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	04/01/23	AQ
ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/11/22	AQ
Alpha Healthcare Acquisition III : Change in Certifying Accountants - Form 8-K	11/10/22	PU
ALPHA HEALTHCARE ACQUISITION CORP III : Changes in Registrant's Certifying Accountant (form 8-K)	11/10/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ALPA HEAL Nasdaq

Actions

ALPAU

US02073F2039

Communiqués

Filtres